These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9527916)

  • 1. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice.
    Santagati MG; Määttä JA; Röyttä M; Salmi AA; Hinkkanen AE
    Virology; 1998 Mar; 243(1):66-77. PubMed ID: 9527916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Semliki Forest virus E2 gene as a virulence determinant.
    Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity.
    Glasgow GM; Killen HM; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():663-8. PubMed ID: 8126464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus.
    Tarbatt CJ; Glasgow GM; Mooney DA; Sheahan BJ; Atkins GJ
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1551-7. PubMed ID: 9225028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replicase complex genes of Semliki Forest virus confer lethal neurovirulence.
    Tuittila MT; Santagati MG; Röyttä M; Määttä JA; Hinkkanen AE
    J Virol; 2000 May; 74(10):4579-89. PubMed ID: 10775594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein.
    Ferguson MC; Saul S; Fragkoudis R; Weisheit S; Cox J; Patabendige A; Sherwood K; Watson M; Merits A; Fazakerley JK
    J Virol; 2015 Aug; 89(15):7536-49. PubMed ID: 25972559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence.
    Tuittila M; Hinkkanen AE
    J Gen Virol; 2003 Jun; 84(Pt 6):1525-1533. PubMed ID: 12771422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2.
    Rikkonen M
    Virology; 1996 Apr; 218(2):352-61. PubMed ID: 8610462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
    Donnelly SM; Sheahan BJ; Atkins GJ
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
    Kim KH; Rümenapf T; Strauss EG; Strauss JH
    Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.
    Fazakerley JK; Boyd A; Mikkola ML; Kääriäinen L
    J Virol; 2002 Jan; 76(1):392-6. PubMed ID: 11739703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
    Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
    Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple repeating motifs are found in the 3'-terminal non-translated region of Semliki Forest virus A7 variant genome.
    Santagati MG; Itäranta PV; Koskimies PR; Määttä JA; Salmi AA; Hinkkanen AE
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1499-504. PubMed ID: 8207416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.
    Galbraith SE; Sheahan BJ; Atkins GJ
    J Gen Virol; 2006 Apr; 87(Pt 4):937-947. PubMed ID: 16528043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression of proinflammatory cytokines in mouse CNS correlates with replication rate of semliki forest virus but not with the strain of viral proteins.
    Tuittila M; Nygårdas P; Hinkkanen A
    Viral Immunol; 2004; 17(2):287-97. PubMed ID: 15279706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5' untranslated region as a pathogenicity determinant of Semliki Forest virus in mice.
    Logue CH; Sheahan BJ; Atkins GJ
    Virus Genes; 2008 Apr; 36(2):313-21. PubMed ID: 18264748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.
    Vähä-Koskela MJ; Tuittila MT; Nygårdas PT; Nyman JK; Ehrengruber MU; Renggli M; Hinkkanen AE
    J Neurovirol; 2003 Feb; 9(1):1-15. PubMed ID: 12587064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.
    Fragkoudis R; Breakwell L; McKimmie C; Boyd A; Barry G; Kohl A; Merits A; Fazakerley JK
    J Gen Virol; 2007 Dec; 88(Pt 12):3373-3384. PubMed ID: 18024907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.